Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Pegylated Interferon alfa 2b and ribavirin
Locations
1
Norway
Ullevaal University Hospital
Oslo, Norway
Start Date
March 1, 2004
Completion Date
September 1, 2006
Last Updated
July 6, 2011
NCT05361603
NCT05975216
NCT05071261
NCT04852614
NCT04251572
NCT04136405
Lead Sponsor
Ullevaal University Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions